Stockreport

INmune Bio Inc. to Host Webinar on Cognitive Testing Using EMACC and CDR-SB

INmune Bio Inc. - Common stock  (INMB) 
PDF “Why EMACC is the Optimal Tool for Measuring Cognitive Change in Early Alzheimer’s Trials” Webinar to be Held on November 7, 2024, at 1 PM ET. Poster on EMACC Sens [Read more]